OOIR: Observatory of International Research

Papers

(The H4-Index of AIDS is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	102
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	89
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	75
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	44
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease	43
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	42
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	40
Trends in population HIV viral suppression: a longitudinal analysis	39
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	34
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	34
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	32
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	31
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	31
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	31
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	30
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals	29
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	29
Social context and tracing household wealth over time in rural Uganda 1994–2018	28
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	28
Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries	27
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	27
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	26
Life expectancy of people with HIV on antiretroviral therapy in Spain	26
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis	24
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	24

Hiv and herpes simplex virus 2 incidence among adolescent girls and young women who sell sex (YWSS) in rural south africa: a population-based cohort study	24
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	24
Real world use of dolutegravir two drug regimens	24
Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy	24